These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 11790695

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.
    Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM.
    N Engl J Med; 2000 Nov 16; 343(20):1445-53. PubMed ID: 11078769
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography.
    Kühl HP, Beek AM, van der Weerdt AP, Hofman MB, Visser CA, Lammertsma AA, Heussen N, Visser FC, van Rossum AC.
    J Am Coll Cardiol; 2003 Apr 16; 41(8):1341-8. PubMed ID: 12706930
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization.
    Knuesel PR, Nanz D, Wyss C, Buechi M, Kaufmann PA, von Schulthess GK, Lüscher TF, Schwitter J.
    Circulation; 2003 Sep 02; 108(9):1095-100. PubMed ID: 12939229
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake.
    Rischpler C, Langwieser N, Souvatzoglou M, Batrice A, van Marwick S, Snajberk J, Ibrahim T, Laugwitz KL, Nekolla SG, Schwaiger M.
    Eur Heart J Cardiovasc Imaging; 2015 Jun 02; 16(6):661-9. PubMed ID: 25680385
    [Abstract] [Full Text] [Related]

  • 12. Influence of contrast agent dose and image acquisition timing on the quantitative determination of nonviable myocardial tissue using delayed contrast-enhanced magnetic resonance imaging.
    Petersen SE, Mohrs OK, Horstick G, Oberholzer K, Abegunewardene N, Ruetzel K, Selvanayagam JB, Robson MD, Neubauer S, Thelen M, Meyer J, Kreitner KF.
    J Cardiovasc Magn Reson; 2004 Jun 02; 6(2):541-8. PubMed ID: 15137338
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of contrast-enhanced MRI with (18)F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease.
    Wu YW, Tadamura E, Yamamuro M, Kanao S, Marui A, Tanabara K, Komeda M, Togashi K.
    J Nucl Med; 2007 Jul 02; 48(7):1096-103. PubMed ID: 17607039
    [Abstract] [Full Text] [Related]

  • 17. Myocardial viability in chronic ischemic heart disease: comparison of delayed-enhancement magnetic resonance imaging with 99mTc-sestamibi and 18F-fluorodeoxyglucose single-photon emission computed tomography.
    Liu Q, Zhao S, Yan C, Lu M, Jiang S, Zhang Y, Li S, Liu Y, Yang M, He Z.
    Nucl Med Commun; 2009 Aug 02; 30(8):610-6. PubMed ID: 19491715
    [Abstract] [Full Text] [Related]

  • 18. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization.
    Yoshida K, Gould KL.
    J Am Coll Cardiol; 1993 Oct 02; 22(4):984-97. PubMed ID: 8409073
    [Abstract] [Full Text] [Related]

  • 19. Analysis of first-pass and delayed contrast-enhancement patterns of dysfunctional myocardium on MR imaging: use in the prediction of myocardial viability.
    Sandstede JJ, Lipke C, Beer M, Harre K, Pabst T, Kenn W, Neubauer S, Hahn D.
    AJR Am J Roentgenol; 2000 Jun 02; 174(6):1737-40. PubMed ID: 10845515
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.